Pay in 4 interest-free payments of $5.11 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
(12) Stefan M, et al
Nava-Mesa, and A.M
Yamamoto K, Sato H, Fujiyama Y, Doida Y, Bamba T
Ligands (e.g., antibodies, peptides or small molecules) may be conjugated with the nanoparticles and these ligands are known to selectively bind to receptors that are over expressed in tumour cells, thus, delivering the antioxidant directly at the tumour site [299, 300]
UK researchers must confirm the current regulatory position with the MHRA and Home Office before purchase, as peptide scheduling can change
Available from: Weghuber D, Barrett T, Barrientos-Perez M, et al
US$ 28.38
US$ 24.87
US$ 27.95
US$ 29.62
US$ 28.00
US$ 28.84
US$ 29.75
US$ 26.56
